Venus Remedies Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent

Circuit Event and Unfilled Demand

The stock of Venus Remedies Ltd hit its upper circuit price limit of Rs 1,729.3 on 13 Aug 2026, representing a 4.8% gain within the 5% price band allowed for the day. This ceiling effectively froze trading at the peak price, signalling that demand exceeded what the price band could accommodate. The stock opened at Rs 1,726 and traded tightly around this level, indicating that buyers were willing to pay the maximum allowed, but sellers were absent. This unfilled demand is a hallmark of upper circuit events, especially in micro-cap stocks where liquidity is thinner and price bands are narrower.

Delivery and Volume Analysis

Volume on the circuit day was 59,929 shares, translating to a turnover of approximately Rs 10.22 crore. While total traded volume is mechanically suppressed on circuit days due to the price lock, the delivery volume data offers deeper insight into the quality of the move. On 12 Aug 2026, delivery volume surged by 179.32% compared to the 5-day average, with 7,550 shares taken in delivery. This sharp rise in delivery volume suggests that the shares traded were not merely speculative intraday bets but were being accumulated for the longer term. Such a pattern lends credibility to the rally and indicates genuine buying conviction rather than a fleeting spike driven by thin liquidity or momentum traders — is this delivery surge a sign of sustained interest or a short-term accumulation phase?

Moving Averages and Trend Context

Venus Remedies Ltd is trading comfortably above all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This alignment confirms a strong bullish trend that preceded the circuit event. The stock’s ability to sustain prices above these technical levels suggests that the upper circuit was not an isolated spike but rather an amplification of an existing upward momentum. The narrow intraday range, with the stock opening at Rs 1,726 and maintaining that level, further underscores the strength of the buyers who were unwilling to sell below the circuit price — does this technical setup indicate a breakout or a temporary peak?

Liquidity and Market Capitalisation

With a market capitalisation of Rs 2,266 crore, Venus Remedies Ltd is classified as a micro-cap stock. The liquidity profile is moderate, with the stock liquid enough to support a trade size of Rs 0.21 crore based on 2% of the 5-day average traded value. While this level of liquidity is sufficient for retail and small institutional investors, it remains limited compared to larger caps. This liquidity constraint means that the upper circuit event carries a dual message: it signals strong buying interest but also highlights the risk of thin order books and difficulty in entering or exiting sizeable positions without impacting the price. For micro-caps, such liquidity risk is as important as the momentum signal itself.

Intraday Price Action

The intraday price action on 13 Aug 2026 was characterised by a tight range, with the stock opening at Rs 1,726 and touching a high of Rs 1,729.3, the circuit price. The low was Rs 1,641.1, indicating some volatility earlier in the session before the stock settled near the upper limit. This pattern is typical of circuit hits where initial price discovery occurs, followed by a consolidation at the ceiling price as buyers queue and sellers withdraw. The weighted average price was closer to the low price, suggesting that most volume traded before the circuit lock was at slightly lower levels, with the final surge pushing the stock to its maximum allowed gain.

Brief Fundamental Context

Venus Remedies Ltd operates in the Pharmaceuticals & Biotechnology sector, an industry known for its growth potential and innovation-driven earnings. The company’s micro-cap status means it is still in a growth phase relative to larger peers. While fundamentals are not the focus of this price action, the sector’s overall resilience and the company’s positioning may provide some backdrop to the buying interest observed in recent sessions.

Conclusion: What the Circuit and Data Signal

The upper circuit hit at a 5% gain, combined with a 179% surge in delivery volume and a position above all major moving averages, paints a picture of genuine buying conviction in Venus Remedies Ltd. However, the micro-cap status and moderate liquidity profile introduce a cautionary note. The circuit locked in gains but also locked out buyers who arrived late, and the limited trade size capacity means that larger investors may find it challenging to build or exit positions without influencing the price. This liquidity risk is a critical factor to consider alongside the positive momentum — after a 5% single-day gain at upper circuit, is Venus Remedies Ltd still worth considering or has the move already happened?

Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →